Clinical Trials Logo

Clinical Trial Summary

The primary objective is to assess the effect of glucose on retinal vascular diameter in otherwise healthy vasospastic subjects compared to non-vasospastic controls. The secondary objective is to compare the effect of glucose also on choroidal blood flow in otherwise healthy vasospastic subjects with non-vasospastic controls.


Clinical Trial Description

It is known that a glucose load can induce an increase in ocular blood flow. Acute hyperglycemia increases retinal vessel diameters in animals and humans. The purpose of this study is to compare the effect of glucose on the ocular blood flow in vasospastics and nonvasospastics. Body core temperature depends on basal metabolism. Peripheral vasoconstriction is a physiological way to preserve core temperature of the body. The etiology of primary vasospastic syndrome is unknown and potentially represents simply a reaction to a defective metabolism. Based on this hypothesis, vasospastics are expected to show a different vascular reaction to glucose. On both study days, after an overnight fast, the subjects will be seated for 30 minutes in the Lab and local tropicamide will be applied for pupil dilatation. After stabilisation of blood pressure Retinal vessel diameter and choroidal blood flow will be assessed. Baseline blood glucose levels will be measured. Afterwards study substance (75 gram of Glucose or Aspartate) will be applied in 3 dl of water. One and a half hour later, the vascular measurements will be repeated. Ath the end of hemodynamic assessments, blood sugar level will be measured again. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00350129
Study type Observational
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase
Start date December 2002
Completion date February 2003

See also
  Status Clinical Trial Phase
Recruiting NCT06125392 - Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition
Recruiting NCT05288361 - The DISCOVER INOCA Prospective Multi-center Registry
Active, not recruiting NCT04777045 - Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial Phase 3
Enrolling by invitation NCT06083155 - The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
Recruiting NCT04598308 - EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial
Completed NCT03193294 - CORonary MICrovascular Angina (CorMicA) N/A
Completed NCT02298543 - Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry N/A
Recruiting NCT00921856 - Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD) N/A
Withdrawn NCT00454714 - Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm Phase 3
Recruiting NCT05635994 - Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)
Completed NCT03930433 - The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm Phase 4
Completed NCT00619294 - Endothelial Dysfunction and Coronary Artery Spasm N/A